PEAK6 LLC Makes New $867,000 Investment in Silicon Laboratories, Inc. $SLAB

Key Points

• PEAK6 LLC has invested approximately $867,000 in Silicon Laboratories, Inc., acquiring 7,705 shares of the semiconductor company's stock.
• Silicon Laboratories reported earnings of $0.11 per share for the latest quarter, exceeding analysts' expectations and showing a 32.6% increase in revenue year-over-year.
• Despite recent performance, analysts have mixed ratings for the stock, with a consensus view of "Moderate Buy" and an average target price of $151.13.

PEAK6 LLC acquired a new stake in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 7,705 shares of the semiconductor company's stock, valued at approximately $867,000.

Other large investors have also modified their holdings of the company. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Silicon Laboratories in the first quarter valued at approximately $34,000. UMB Bank n.a. boosted its holdings in shares of Silicon Laboratories by 111.3% in the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock valued at $38,000 after acquiring an additional 177 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Silicon Laboratories by 143.7% in the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock valued at $52,000 after acquiring an additional 273 shares during the period. Larson Financial Group LLC acquired a new stake in shares of Silicon Laboratories during the first quarter worth about $55,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of Silicon Laboratories during the first quarter worth about $77,000.

Silicon Laboratories Stock Performance

Silicon Laboratories stock traded up $2.38 during midday trading on Thursday, reaching $133.41. The company's stock had a trading volume of 68,189 shares, compared to its average volume of 401,052. Silicon Laboratories, Inc. has a fifty-two week low of $82.82 and a fifty-two week high of $160.00. The stock's 50 day simple moving average is $137.97 and its 200 day simple moving average is $127.30. The firm has a market capitalization of $4.38 billion, a PE ratio of -41.46 and a beta of 1.52.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The company had revenue of $192.85 million during the quarter, compared to the consensus estimate of $192.57 million. During the same quarter last year, the company earned ($0.56) earnings per share. Silicon Laboratories's quarterly revenue was up 32.6% compared to the same quarter last year. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Equities analysts predict that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current year.

Insider Activity

In related news, SVP Brandon Tolany sold 8,000 shares of Silicon Laboratories stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the completion of the transaction, the senior vice president directly owned 62,328 shares in the company, valued at $9,051,895.44. The trade was a 11.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last three months, insiders sold 12,070 shares of company stock worth $1,703,472. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Benchmark reiterated a "buy" rating and set a $160.00 target price on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Morgan Stanley decreased their target price on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 6th. Stifel Nicolaus increased their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a research note on Friday, July 18th. Barclays increased their price target on Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 5th. Finally, Susquehanna increased their price target on Silicon Laboratories from $110.00 to $150.00 and gave the stock a "neutral" rating in a report on Tuesday, July 22nd. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $151.13.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.